Brief: Victory Square Company Announces Access to Tirzepatide and GLP-1 Injections to its Weight Loss Portfolio
23/05/2024 13:35
May 23 (Reuters) - Hydreight Technologies Inc NURS.V :
* VICTORY SQUARE COMPANY ANNOUNCES ACCESS TO TIRZEPATIDE AND
GLP-1
INJECTIONS TO ITS WEIGHT LOSS PORTFOLIO
Source text for Eikon: ID:nGNX9ZmWdp
Further company coverage: NURS.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Victory Square Technologies
See all newsCanada's Victory Square Q2 revenue jumps on Hydreight strength
Brief: Victory Square Provides Update On Hydreight And Healthcare Investments Following FDA Advisory Committee Recommendations On Peptide-Related Bulk Drug Substances
Brief: Victory Square Provides Update On Hydreight And Healthcare Investments Following FDA Advisory Committee Recommendations On Peptide-Related Bulk Drug Substances
Brief: Victory Square Technologies Declares Special Common Share Dividend Of Its Interest In Yocale.ai
Brief: Hydreight Technologies Signs Binding Letter Of Intent To Acquire Dynamic Iv Therapy Support Ai Agent